Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Milestone Pharmaceuticals Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 43 | 40 | −3 |
| Shares | 31.3M | 30.2M | −1.16M (−3.7%) |
| Value | $56.4M | $39.9M | −$16.5M (−29.3%) |
New holders (3)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Squarepoint Ops LLC | 54,684 | $72.7K | 0.00% |
| Atria Investments LLC | 27,991 | $36.9K | 0.00% |
| Jones Financial Companies LLLP | 1,070 | $1.41K | 0.00% |
Sold out (6)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Velan Capital Investment Management LP | 650,000 | $1.16M |
| Monashee Investment Management LLC | 500,000 | $895.0K |
| Bank of Montreal | 273,100 | $786.5K |
| XTX Topco Ltd | 13,403 | $24.0K |
| UBS Group AG | 2,618 | $4.69K |
| ICA Group Wealth Management, LLC | 200 | $358 |